Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 4)

v3.8.0.1
Stockholders' Equity (Details 4)
9 Months Ended 12 Months Ended
Sep. 30, 2017
$ / shares
shares
Dec. 31, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Warrants, Outstanding Beginning of year | shares 2,243,664  
Warrants, Granted | shares 3,013,770  
Warrants, Outstanding End of year | shares 5,257,434 2,243,664
Weighted Average Exercise Price, Outstanding Beginning of year | $ / shares $ 7.98  
Weighted Average Exercise Price, Granted | $ / shares 8.5  
Weighted Average Exercise Price, Outstanding End of year | $ / shares $ 8.28 $ 7.98
Weighted Average Remaining Contractual Life, Granted (in years) 4 years 4 months 2 days  
Weighted Average Remaining Contractual Life, Outstanding (in years) 4 years 4 months 13 days 5 years 1 month 28 days